Ono Pharmaceuticals is spending $280 million upfront to take the global rights of Ionis Pharmaceuticals’ asset for a rare ...
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...
After hours: March 14 at 6:48:41 PM EDT Loading Chart for IOBT ...
Title Boron-Directed Regioselective Aromatic Ortho Functionalizations Opponent Professor Michael Ingleson, School of Chemistry, University of Edinburgh, UK The examination board Professor Peter Somfai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback